U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from Gene

Items: 1 to 20 of 905

1.
Downregulation of miR‐138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines
Shingo Mitomo, Chihaya Maesawa, Satoshi Ogasawara, Takeshi Iwaya, Masahiko Shibazaki, Akiko Yashima‐Abo, Koji Kotani, Hiroki Oikawa, Eiich Sakurai, Naoko Izutsu, Kuniyuki Kato, Hideaki Komatsu, Kenichro Ikeda, Go Wakabayashi, Tomoyuki Masuda
Cancer Sci. 2008 Feb; 99(2): 280–286. Published online 2008 Jan 14. doi: 10.1111/j.1349-7006.2007.00666.x
PMCID:
PMC11159409
AbstractArticlePDF–271K
2.
Quantitative analysis of hTERT mRNA levels in cells microdissected from cytological specimens
Hayato Fujita, Kenoki Ohuchida, Kazuhiro Mizumoto, Takuya Egami, Yoshihiro Miyasaka, Hiroshi Yamaguchi, Jun Yu, Lin Cui, Manabu Onimaru, Shunichi Takahata, Masazumi Tsuneyoshi, Masao Tanaka
Cancer Sci. 2008 Nov; 99(11): 2244–2251. Published online 2008 Sep 15. doi: 10.1111/j.1349-7006.2008.00930.x
PMCID:
PMC11159216
AbstractArticlePDF–529K
3.
Establishment of functional telomerase immortalized human hepatocytes and a hepatic stellate cell line for telomere‐targeting anticancer drug development
Koji Waki, Kumiko Anno, Taeko Ono, Toshinori Ide, Kazuaki Chayama, Hidetoshi Tahara
Cancer Sci. 2010 Jul; 101(7): 1678–1685. Published online 2010 Mar 23. doi: 10.1111/j.1349-7006.2010.01576.x
PMCID:
PMC11159078
AbstractArticlePDF–758K
4.
Alternative lengthening of telomeres in hTERT‐inhibited laryngeal cancer cells
Wei Chen, Bo‐Kui Xiao, Jun‐Ping Liu, Shi‐Ming Chen, Ze‐Zhang Tao
Cancer Sci. 2010 Aug; 101(8): 1769–1776. Published online 2010 May 8. doi: 10.1111/j.1349-7006.2010.01611.x
PMCID:
PMC11159073
AbstractArticlePDF–956K
5.
The association of telomere maintenance and TERT expression with susceptibility to human papillomavirus infection in cervical epithelium
Li-Na Wang, Li Wang, Guanghui Cheng, Mingkai Dai, Yunhai Yu, Guoxin Teng, Jingjie Zhao, Dawei Xu
Cell Mol Life Sci. 2022 Feb; 79(2): 110. Published online 2022 Jan 31. doi: 10.1007/s00018-021-04113-0
PMCID:
PMC11072999
AbstractArticlePDF–1023K
6.
Clinical features combined with ultrasound characteristics to predict TERT promoter mutations in papillary thyroid carcinoma: a single-center study over the past 5 years
Yan Hu, Shangyan Xu, Lei Dong, Zuxian Pan, Lu Zhang, Weiwei Zhan
Front Endocrinol (Lausanne) 2024; 15: 1322731. Published online 2024 Mar 18. doi: 10.3389/fendo.2024.1322731
PMCID:
PMC10982409
AbstractArticlePDF–1.8M
7.
Telomere length and TERT polymorphisms as biomarkers in asbestos-related diseases
Ana Mervic, Katja Goricar, Tanja Blagus, Alenka Franko, Katarina Trebusak-Podkrajsek, Metoda Dodic Fikfak, Vita Dolzan, Viljem Kovac
Radiol Oncol. 2024 Mar; 58(1): 87–98. Published online 2024 Feb 21. doi: 10.2478/raon-2024-0009
PMCID:
PMC10878767
AbstractArticlePDF–740K
8.
The regulations of telomerase reverse transcriptase (TERT) in cancer
Mingdi Liu, Yuning Zhang, Yongping Jian, Liting Gu, Dan Zhang, Honglan Zhou, Yishu Wang, Zhi-Xiang Xu
Cell Death Dis. 2024 Jan; 15(1): 90. Published online 2024 Jan 26. doi: 10.1038/s41419-024-06454-7
PMCID:
PMC10817947
AbstractArticlePDF–1.4M
9.
Association of Ultrasonography Features of Follicular Thyroid Carcinoma With Tumor Invasiveness and Prognosis Based on WHO Classification and TERT Promoter Mutation
Myoung Kyoung Kim, Hyunju Park, Young Lyun Oh, Jung Hee Shin, Tae Hyuk Kim, Soo Yeon Hahn
Korean J Radiol. 2024 Jan; 25(1): 103–112. Published online 2024 Jan 2. doi: 10.3348/kjr.2023.0461
PMCID:
PMC10788599
AbstractArticlePDF–594K
10.
Genetic association study of TERT gene variants with chronic kidney disease susceptibility in the Chinese population
Yan Su, Yuan Feng, Xinran Lin, Chunyang Ma, Jiali Wei
Ren Fail. 2024; 46(1): 2300725. Published online 2024 Jan 10. doi: 10.1080/0886022X.2023.2300725
PMCID:
PMC10783823
AbstractArticlePDF–1.7M
11.
Age-associated mortality is partially mediated by TERT promoter mutation status in differentiated thyroid carcinoma
Jung Heo, Sungjoo Lee, Jun Park, Heera Yang, Hyunju Park, Chang-Seok Ki, Young Lyun Oh, Hye In Kim, Sun Wook Kim, Jae Hoon Chung, Kyunga Kim, Tae Hyuk Kim
PLoS One. 2023; 18(11): e0294145. Published online 2023 Nov 10. doi: 10.1371/journal.pone.0294145
PMCID:
PMC10637683
AbstractArticlePDF–1.4M
12.
Effect of the TERT mutation on the prognosis of patients with urothelial carcinoma: a systematic review and meta-analysis
Hui Shuai, Xi Duan, Jun-Jie Zhou, Yuan Liu, Tao Wu
BMC Urol. 2023; 23: 177. Published online 2023 Nov 2. doi: 10.1186/s12894-023-01349-9
PMCID:
PMC10621162
AbstractArticlePDF–1.5M
13.
Clinicopathological and Prognostic Values of Telomerase Reverse Transcriptase (TERT) Promoter Mutations in Ovarian Clear Cell Carcinoma for Predicting Tumor Recurrence, Platinum Resistance and Survival
HYUNWOO YOO, HYUN-SOO KIM
Cancer Genomics Proteomics. 2023 Nov-Dec; 20(6): 626–636. Published online 2023 Nov 3. doi: 10.21873/cgp.20411
PMCID:
PMC10614067
AbstractArticlePDF–4.9M
14.
Association of TERT (rs2736098 and rs2736100) genetic variants with elevated risk of hepatocellular carcinoma: a retrospective case–control study
Walaa R. Seif Eldin, Entsar A. Saad, Ahmed Monier, Rami M. Elshazli
Sci Rep. 2023; 13: 18382. Published online 2023 Oct 26. doi: 10.1038/s41598-023-45716-w
PMCID:
PMC10603040
AbstractArticlePDF–7.2M
15.
Copy-number-gain of telomerase reverse transcriptase (hTERT) is associated with an unfavorable prognosis in esophageal adenocarcinoma
Su Ir Lyu, Felix C. Popp, Adrian Georg Simon, Anne Maria Schultheis, Thomas Zander, Caroline Fretter, Wolfgang Schröder, Christiane J. Bruns, Thomas Schmidt, Alexander Quaas, Karl Knipper
Sci Rep. 2023; 13: 17699. Published online 2023 Oct 17. doi: 10.1038/s41598-023-44844-7
PMCID:
PMC10582081
AbstractArticlePDF–1.3M
16.
Alteration of relative telomere length and telomerase reverse transcriptase expression in the granulosa cells of women during aging and assessment of in vitro fertilization outcomes
Yan Hao, Mingrong Lv, Jing Peng, Dan Kuang, Zhihua Zhang, Zhou Zhang, Tingting Wang, Bo Yang, Zhaolian Wei, Ping Zhou, Zhiguo Zhang, Yunxia Cao
Mol Med Rep. 2023 Nov; 28(5): 206. Published online 2023 Sep 18. doi: 10.3892/mmr.2023.13093
PMCID:
PMC10540000
AbstractArticlePDF–769K
17.
Transition Mutations in the hTERT Promoter Are Unrelated to Potential i-motif Formation in the C-Rich Strand
James W. Conrad, Mark L. Sowers, Dianne Y. Yap, Ellie Cherryhomes, B. Montgomery Pettitt, Kamil Khanipov, Lawrence C. Sowers
Biomolecules. 2023 Sep; 13(9): 1308. Published online 2023 Aug 25. doi: 10.3390/biom13091308
PMCID:
PMC10526324
AbstractArticlePDF–5.9M
18.
Accumulation of TERT in mitochondria exerts two opposing effects on apoptosis
Hiroshi Ebata, Tomohiro Shima, Ryo Iizuka, Sotaro Uemura
FEBS Open Bio. 2023 Sep; 13(9): 1667–1682. Published online 2023 Aug 8. doi: 10.1002/2211-5463.13682
PMCID:
PMC10476567
AbstractArticlePDF–2.1M
19.
Ethnicity-specific association between TERT rs2736100 (A > C) polymorphism and lung cancer risk: a comprehensive meta-analysis
Xiaozheng Wu, Gao Huang, Wen Li, Yunzhi Chen
Sci Rep. 2023; 13: 13271. Published online 2023 Aug 15. doi: 10.1038/s41598-023-40504-y
PMCID:
PMC10427644
AbstractArticlePDF–3.8M
20.
Prognostic value and immune landscapes of TERT promoter methylation in triple negative breast cancer
Fei Lin, Jiajia Huang, Wancui Zhu, Tongchao Jiang, Jia Guo, Wen Xia, Miao Chen, Ling Guo, Wuguo Deng, Huanxin Lin
Front Immunol. 2023; 14: 1218987. Published online 2023 Jul 28. doi: 10.3389/fimmu.2023.1218987
PMCID:
PMC10416624
AbstractArticlePDF–9.2M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center